Your browser doesn't support javascript.
loading
GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding.
Zeng, Haoyang; Hashimoto, Tatsunori; Kang, Daniel D; Gifford, David K.
Afiliação
  • Zeng H; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02142, USA and.
  • Hashimoto T; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02142, USA and.
  • Kang DD; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02142, USA and.
  • Gifford DK; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02142, USA and Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School, Cambridge, MA 02138, USA.
Bioinformatics ; 32(4): 490-6, 2016 Feb 15.
Article em En | MEDLINE | ID: mdl-26476779
ABSTRACT
MOTIVATION The majority of disease-associated variants identified in genome-wide association studies reside in noncoding regions of the genome with regulatory roles. Thus being able to interpret the functional consequence of a variant is essential for identifying causal variants in the analysis of genome-wide association studies.

RESULTS:

We present GERV (generative evaluation of regulatory variants), a novel computational method for predicting regulatory variants that affect transcription factor binding. GERV learns a k-mer-based generative model of transcription factor binding from ChIP-seq and DNase-seq data, and scores variants by computing the change of predicted ChIP-seq reads between the reference and alternate allele. The k-mers learned by GERV capture more sequence determinants of transcription factor binding than a motif-based approach alone, including both a transcription factor's canonical motif and associated co-factor motifs. We show that GERV outperforms existing methods in predicting single-nucleotide polymorphisms associated with allele-specific binding. GERV correctly predicts a validated causal variant among linked single-nucleotide polymorphisms and prioritizes the variants previously reported to modulate the binding of FOXA1 in breast cancer cell lines. Thus, GERV provides a powerful approach for functionally annotating and prioritizing causal variants for experimental follow-up analysis. AVAILABILITY AND IMPLEMENTATION The implementation of GERV and related data are available at http//gerv.csail.mit.edu/.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Algoritmos / Sequências Reguladoras de Ácido Nucleico / Modelos Estatísticos / Biologia Computacional / Polimorfismo de Nucleotídeo Único Tipo de estudo: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Algoritmos / Sequências Reguladoras de Ácido Nucleico / Modelos Estatísticos / Biologia Computacional / Polimorfismo de Nucleotídeo Único Tipo de estudo: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bioinformatics Assunto da revista: INFORMATICA MEDICA Ano de publicação: 2016 Tipo de documento: Article